The acquisition of TargImmune Therapeutics is expected to significantly enhance iOncologi's product offerings and market position.
Company Description
iOncologi is a biotechnology company focused on developing innovative therapies for cancer treatment. The acquisition of TargImmune Therapeutics enhances its capabilities in immunotherapy.